glp-1 prescriptions growth slowing 2024 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Prescribing Is Rising —

The Definitive 2026 Guide to Retatrutide The landscape of metabolic science is currently witnessing a paradigm shift, driven by the emergence of multi-receptor agonists

References Int J Mol Sci (MDPI) Overview of Epitalon: Highly Bioactive Pineal Tetrapeptide with Promising Properties (2025) PMC/Biogerontology Epitalon increases telomere length in human cell lines through telomerase upregulation Neuroendocrinology Letters (PubMed) Synthetic tetrapeptide Epitalon restores neuroendocrine regulation in senescent monkeys Bull Exp Biol Med (PubMed) Geroprotective effect of epithalamine in elderly with accelerated aging (12-year RCT) Alzheimers Drug Discovery Foundation Epithalamin/Epithalon Cognitive Vitality Report (mechanisms, dosing, safety) JPT Peptide Technologies Peptide Stability: How Long Do Peptides Last

L.ShefnerJ

While GLP-1 medications show promise and may offer benefits, it's crucial to weigh the potential risks and have an in-depth discussion with your healthcare team

Six subjects entered the study on allopurinol, but at doses where they still were hyperuricemic and therefore not at serum urate target

doi: 10.1111/jgh.14583 139 TedelindSWestbergFKjerrulfMVidalA